# AFTERNOON Agentic Swing/Rotation Scan — 2026-08-15

- Timestamp: 2026-08-15 19:16 UTC / 15:16 ET (Saturday)
- Account: Robinhood Agentic ••••1041 / 433711041 only
- Policy: `playbook/autonomous-policy.md` ACTIVE
- Decision: **NO ORDERS — market closed; AVGO thesis invalidated and flagged for next-session exit review. Hold MA, BAC, SHOP.**

## Broker state and gates

- Authorized account verified active cash account, `agentic_allowed=true`; no other account used.
- Account value $335.0882; equities $302.9782; cash and authoritative buying power $32.11; unsettled funds $0; pending deposits $0.
- Kill switch clear: value >$10. Account is above the Aug. 12 pre-action value of $332.50, so neither the 5% daily nor 10% recent-high pause is indicated by available snapshots.
- Four long fractional equities, all fully sellable: AVGO 0.095750 @ $411.28; MA 0.113541 @ $572.48; BAC 1.046363 @ $62.12; SHOP 0.862075 @ $144.09.
- Open-ish equity states checked separately: new, queued, confirmed, unconfirmed, partially_filled; all empty. Pending commitment $0.
- Recent fills checked from Aug. 8: NESR buy 0.736516 @ $33.7399 on Aug. 10 and sell 0.736516 @ $35.1601 on Aug. 12; estimated realized gain +$1.05, fees $0. No later fill found.
- Broker reads were coherent, but the equity market was closed and quote timestamps were from Aug. 14. Weekend quotes/spreads are not executable live state; no review or placement was attempted.

## Liquid-balance math

- Liquid buying power after pending orders: $32.11.
- Policy marginal deployment target: $25.69 (80%); designated reserve: $6.42 (20%).
- Existing portfolio exposure is separate: equity is 90.42% of account value and cash is 9.58%.
- Deployed this run: $0. The $25.69 qualifying portion remains undeployed because the market is closed and no entry can be confirmed without live Monday price/volume.

## Regime / macro / sector read (through Friday Aug. 14)

- Mixed risk-on rotation: SPY $776.01, above SMA20 $756.20 and SMA50 $748.93; IWM $304.90, above SMA20 $296.72 and at a fresh 52-week high. Friday itself was flat/soft in SPY/QQQ while IWM, energy and industrials outperformed.
- Sector evidence: XLE +1.4% Friday and near its 52-week high; XLI positive and near its high; XLF near its high; XLK and XLV lagged Friday. Public sector research favors industrials/financials and identifies strong 2026 energy leadership, while technology is more selective.
- Macro: July CPI/PPI were characterized as roughly in line/subdued but still above the Fed's 2% objective; July retail sales unexpectedly fell 0.6%. Rate-hike risk remains material and low VIX implies complacency. Upcoming earnings include HD Aug. 18, TJX/TGT/LOW Aug. 19, and WMT Aug. 20, creating consumer read-through risk.

## Position decisions

Stops are scan-managed invalidations, not resting orders.

1. **BAC — HOLD, 14/16.** Friday $64.4782; value ~$67.47; unrealized +$2.47 (+3.80%). Above SMA20 $62.61 and SMA50 $59.64, near $65.20 52-week resistance; ATR14 $1.04. Q2 revenue $31.56B and net income $9.07B improved year over year. Keep binding stop $61.40; targets $66/$68. No add at resistance.
2. **SHOP — HOLD / protect winner, 12/16.** Friday $154.50; value ~$133.19; unrealized +$8.97 (+7.22%). Above SMA20 $133.61 and SMA50 $122.92, ATR14 $7.23, but Friday -2.6% on only ~47% of 30-day average volume. Q2 revenue $3.58B and net margin 41.92% improved sharply, but PE ~104 and consumer/retail data risk argue against adding. Keep binding stop $143.50; targets $160/$166; review profit protection if $160 stalls.
3. **MA — HOLD / weakest valid holding, 10/16.** Friday $569.29; value ~$64.64; unrealized -$0.36 (-0.56%). Above SMA20 $559.40 and SMA50 $529.25; ATR14 $10.92. Q2 revenue $9.28B, net income $4.39B, margin 47.3% support quality. Keep $550 invalidation and $583.70/$596 targets. Rotate only for a confirmed 13+ setup.
4. **AVGO — EXIT REVIEW AT NEXT LIQUID SESSION, 8/16.** Friday $393.5485; value ~$37.68; unrealized -$1.70 (-4.31%). It closed below the written $410 binding invalidation and below SMA20 $399.49 after a -5.9% session on ~1.6x average volume; it is only marginally above SMA50 $390.46 and ATR14 is $16.62. Revenue/margins remain strong and AI demand is a valid long-term catalyst, but the swing thesis and relative-strength condition failed. Do not average down or widen the stop. Recheck Monday live quote/spread and exit if it has not decisively reclaimed $410; do not queue a blind weekend market order.

Approximate risk for still-valid MA/BAC/SHOP stops is $3.81. AVGO is already beyond its planned invalidation and is treated as pending exit review, not as risk that may be widened.

## Ranked fresh candidates

1. **JPM — 13/16 WATCH / preferred rotation candidate.** Friday $362.60, above SMA20 $354.62 and SMA50 $339.37, ATR14 $6.33 and near $366.50 resistance. High liquidity, PE ~15.5, improving revenue/net income. Trigger only on a $355–360 retest hold or breakout-retest above $366.50; stop $345; targets $385/$395. Avoid simultaneous over-concentration with BAC.
2. **NVDA — 12/16 WATCH, reduced-size only.** Friday $224.7484, above SMA20 $210.40/SMA50 $206.52; ATR14 $6.93; strong revenue and margin trend. Upcoming Aug. 26 earnings and semiconductor correlation with AVGO reduce score. Trigger $216–220 retest hold or confirmed >$227.50 breakout-retest; stop $205; targets $236.50/$250. No chase.
3. **CAT — 9/16 NO TRADE.** Friday $859.65, near SMA20 $853.61 but below SMA50 $912.53; ATR14 $35.97. Q2 revenue and margin improved and industrial flows are supportive, but intermediate technical damage and wide stop fail current sandbox risk math. Require a base and SMA50 reclaim.

## Actions / fills

- Order reviews: 0
- Orders placed/canceled: 0
- Exact fills this run: 0
- Position changes: 0
- No options, shorts, averaging down, widened stops, other-account action, or guaranteed-return claim.

## Next-session triggers

1. Verify Monday live account, all open-ish states, quote/spread and opening volume.
2. Prioritize AVGO exit review; sell if the failed-$410 thesis remains invalidated rather than waiting for an 8% loss.
3. Deploy up to the then-current 80% qualifying liquid-balance amount only after a confirmed retest; preserve the 20% reserve and aggregate planned risk near $6.
